Van Well Daan 4/A

What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), received equity awards on 2026-04-02: 97,536 restricted stock units (RSUs) and 142,216 derivative RSUs (both reported as acquisitions at $0.00), for a total of 239,752 awarded/derivative units. After the transaction the corrected beneficial ownership is 358,774 ordinary shares (per amended filing). These are awards (not purchases or sales) and require continued service to vest.

Key Details

• Transaction date: 2026-04-02; Form 4/A filed 2026-04-08 to amend prior Form 4 (filed 2026-04-03).
• Reported consideration: $0.00 per share for both items (award/grant code A).
• New awards: 97,536 RSUs + 142,216 derivative RSUs = 239,752 units.
• Shares beneficially owned following transaction (corrected): 358,774 ordinary shares (correction from originally reported 97,536).
• Footnote F1: RSUs granted under the 2021 Equity Incentive Plan; each RSU converts to one ordinary share upon vesting and is contingent on continued service. 25% vests on April 2, 2027, remainder vests in equal quarterly installments through April 2, 2030.
• Footnote F2: This is an amended filing to correct the amount in Column 5 (beneficial ownership).
• Filing timeliness: original Form 4 was filed promptly (Apr 3) for the Apr 2 transaction; this Form 4/A corrects a reporting error (not a late-report signal).

Context
RSUs are derivative awards that convert to actual shares only as they vest; they do not represent an immediate cash purchase or sale. Grants like this are common for executive compensation and signal company-level retention/compensation actions rather than an open-market bet by the insider. The amended Form 4 simply corrects the reported post-transaction ownership total.